Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Expert Review of Gastroenterology & Hepatology|December 9, 2015
Novel approaches to treating Clostridium difficile-associated colitisDavid Padua, Charalabos PothoulakisLife Sciences|June 18, 2019
Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formationCarl Robert Rankin, Zulfiqar Ali Lokhandwala, Raymond Huang, et al.Peptides|July 29, 2006
Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammationDezheng Zhao, Charalabos PothoulakisAnnals of the New York Academy of Sciences|December 17, 2008
Neuropeptides, mesenteric fat, and intestinal inflammationIordanes Karagiannides, Charalabos PothoulakisCurrent Opinion in Gastroenterology|October 2, 2007
Obesity, innate immunity and gut inflammationIordanes Karagiannides, Charalabos PothoulakisCurrent Opinion in Endocrinology, Diabetes, and Obesity|December 24, 2008
Substance P, obesity, and gut inflammationIordanes Karagiannides, Charalabos PothoulakisTherapeutic Advances in Gastroenterology|March 17, 2012
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTheodoros Kelesidis, Charalabos PothoulakisExpert Opinion on Therapeutic Targets|September 23, 2003
Rho GTPases as therapeutic targets for the treatment of inflammatory diseasesDezheng Zhao, Charalabos PothoulakisCurrent Opinion in Gastroenterology|February 9, 2005
Bacterial infections: small intestine and colonStavros Sougioultzis, Charalabos PothoulakisInflammatory Bowel Diseases|March 9, 2007
Role of neuropeptides in inflammatory bowel diseaseKara J Gross, Charalabos PothoulakisPageof 18